FHIR IG analytics| Package | hl7.fhir.uv.ebm |
| Resource Type | EvidenceVariable |
| Id | EvidenceVariable-5269.json |
| FHIR Version | R6 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: EvidenceVariable 5269
version: 21; Last updated: 2026-08-05 07:33:36+0000
Profile: VariableDefinition
ArtifactPublicationStatus: Active
url: https://fevir.net/resources/EvidenceVariable/5269
identifier: FEvIR Object Identifier/5269, FEvIR Linking Identifier/NCT04401202-primaryOutcome-0
name: Percentage_of_Participants_With_Clinical_Recovery_Within_14_Days_After_Randomization_NCT04401202
title: Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202)
citeAs:
Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 5269. Revised 2026-08-05. Available at: https://fevir.net/resources/EvidenceVariable/5269. Computable resource at: https://fevir.net/resources/EvidenceVariable/5269#json.
status: Active
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms)
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Concept |
| Percentage of Participants With Clinical Recovery Within 14 Days After Randomization The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms) |
handling: Evidence variable handling not specified
| Text |
| Day 14 |
{
"resourceType": "EvidenceVariable",
"id": "5269",
"meta": {
"versionId": "21",
"lastUpdated": "2026-08-05T07:33:36.353Z",
"profile": [
"http://hl7.org/fhir/uv/ebm/StructureDefinition/variable-definition"
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
"valueCodeableConcept": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
"code": "active",
"display": "Active"
}
]
}
}
],
"url": "https://fevir.net/resources/EvidenceVariable/5269",
"identifier": [
{
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0203",
"code": "ACSN",
"display": "Accession ID"
}
],
"text": "FEvIR Object Identifier"
},
"system": "https://fevir.net/FOI",
"value": "5269",
"assigner": {
"display": "Computable Publishing LLC"
}
},
{
"type": {
"text": "FEvIR Linking Identifier"
},
"system": "https://fevir.net/FLI",
"value": "NCT04401202-primaryOutcome-0",
"assigner": {
"display": "Computable Publishing LLC"
}
}
],
"name": "Percentage_of_Participants_With_Clinical_Recovery_Within_14_Days_After_Randomization_NCT04401202",
"title": "Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202)",
"citeAs": "Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 5269. Revised 2026-08-05. Available at: https://fevir.net/resources/EvidenceVariable/5269. Computable resource at: https://fevir.net/resources/EvidenceVariable/5269#json.",
"status": "active",
"author": [
{
"name": "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter"
}
],
"publisher": "Computable Publishing LLC",
"contact": [
{
"telecom": [
{
"system": "email",
"value": "support@computablepublishing.com"
}
]
}
],
"description": "The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms)",
"copyright": "Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).",
"definition": {
"concept": {
"text": "Percentage of Participants With Clinical Recovery Within 14 Days After Randomization The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms)"
}
},
"handling": {
"coding": [
{
"system": "https://fevir.net/resources/CodeSystem/179423",
"code": "evidence-variable-handling-not-specified",
"display": "Evidence variable handling not specified"
}
]
},
"timing": {
"text": "Day 14"
}
}